FDA Announces New Public Workshop

Source: PharmaManufacturing.com

Aug 07, 2013


The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), is announcing a public workshop entitled “Synergizing Efforts in Standards Development for Cellular Therapies and Regenerative Medicine Products.” The purpose of the public workshop is to bring together a broad range of stakeholders to discuss current and future standards development activities involving cellular therapies and regenerative medicine products.

Workshop Info:
October 7, 2013
8:30 a.m - 4:30 p.m.
FDA White Oak Campus
The Great Room, Bldg. 31
10903 New Hampshire Ave
Silver Spring, MD 20993

The public workshop will also be available to be viewed online via webcast. Read more
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments